socalTECH

OCTOBER 18, 2012

San Diego-based venture investor Avalon Ventures has backed a developer of video advertising products, Selectable Media , to the tune of $2M. Selectable Media, which is based in New York, lets users opt into branded video advertising in exchange for free access to content on web and mobile apps. READ MORE>>.

Avalon 147

Avalon Media San Diego Advertising 147

socalTECH

JUNE 15, 2015

San Diego-based Avalon Ventures said this morning that it has launched and funded three, new companies as part of its deal with GSK. Avalon Venturs said that Adrenergics , CadheRx Therapeutics , and Calporta Therapeutics have all received $10M in Series A funding, and will receive R&D support from Avalon Ventures and GSK.

Avalon 100

Avalon San Diego Startup Funding 100

socalTECH

DECEMBER 2, 2010

San Diego-based venture capital firm Avalon Ventures has led an investment in a cloud computing company, Standing Cloud , based in Boulder, Colorado. According to Standing Cloud, it received a $3M, Series B financing from Avalon, which also included the firm's prior investor, The Foundry Group.

Avalon 154

Avalon Invest Cloud Computing San Diego 154

Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Develop Development 56

socalTECH

JUNE 11, 2021

Janux Therapeutics is developing T cell engager immunotherapies. The company's biggest shareholders before the IPO were Avalon Ventures, RA Capital Healthcare, Orbimed, Bregua Corporation, and Correlation Ventures. The company begins trading this morning on the Nasdaq Global market under the ticker symbol JANX.

Pricing 113

Pricing Avalon Capital Marketing 113

socalTECH

MARCH 29, 2021

San Diego-based Fortis Therapeutics, a biotechnology startup developing treatments for late-stage prostate cancer and multiple myeloma, has raised $40M in a Series A financing, the company said on Monday.

Avalon 113

Avalon San Diego Research Funding 113

socalTECH

JULY 18, 2013

in venture capital investments in Q2 2013 across Southern California, spread across 80 deals. The report comes every quarter from PricewaterhouseCoopers LLP (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters. in investments across 90 deals. in investments across 90 deals. READ MORE>>.

Southern California 187

Southern California Venture Capital Tech Coast Angels Capital 187

socalTECH

NOVEMBER 22, 2013

San Diego-based Avalon Ventures announced this morning that it has launched a new company, Sitari Pharmaceuticals , with $10M in a Series A financing. disease celiac lifescience biotech capital venture glaxosmithkline pharmaceuticals sitary ventures avalong' READ MORE>>.

Avalon 153

Avalon San Diego Capital Funding 153

Xconomy

SEPTEMBER 27, 2016

Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups).

Avalon 40

Avalon Funding Startup San Diego 40

socalTECH

OCTOBER 22, 2014

San Diego-based StackIQ , which develops IT automation tools for the enterprise, has raised $6M in a Series B funding round, according to the company. The new funding came from Grayhawk Capital, Keshif Ventures, DLA Piper, and OurCrowd, as well as Anthem Venture Partners and Avalon Ventures. The company is led by Tim McIntire.

Avalon 174

Avalon Anthem San Diego Venture Capital 174

socalTECH

JULY 14, 2017

San Diego-based StackIQ , a developer of "bare metal" provisioning software, has been acquired by Teradata , Teradata said on Thursday. StackIQ was venture backed by Anthem Venture Partners, Grayhawk Capital, Avalon Ventures, and crowdfunding site OurCrowd. Financial terms of the acquisition were not announced.

Avalon 113

Avalon Anthem San Diego Acquisition 113

socalTECH

MARCH 31, 2020

San Diego-based AristaMD , a developer of telehealth software, which allows primary care providers to conduct and document electronic medical consultations, has raised $18M in a Series B funding round.

Funding 140

Funding Avalon San Diego Platform 140

socalTECH

SEPTEMBER 27, 2016

The funding was led by Avalon Ventures and also included Bregua Corporation, Lilly Asia Ventures, Osage University Partners, and Vivo Capital. The startup, based in the COI Pharmaceuticals cluster of companies in San Diego, is based on research developed by Bin Liu, Ph.D., READ MORE>>.

Avalon 100

Avalon San Diego Research Capital 100

socalTECH

JULY 28, 2020

San Diego-based telemedicine and telehealth software developer AristaMD has added another $6M to the company's Series B, bringing the total to $24M, the company said on Monday. AristaMD develops telehealth software used for virtual consultations, allowing primary care physicians to consult with medical specialists virtually.

Funding 100

Funding Avalon San Diego Software Development 100

socalTECH

JULY 20, 2016

San Diego-based Synthorx , a developer of protein therapeutics technology, said it has raised $10M in a Series B financing this morning. The funding was led by RA Capital Management, and also included Avalon Ventures and Correlation Ventures. RA Capital Management's Andrew Levin joins the company's board with the funding.

Avalon 100

Avalon San Diego Research Capital 100

socalTECH

JANUARY 9, 2014

The company said the funding came from Avalon Ventures, and also included Torrey Pines Investment, WuXi AppTec, and an additional, un-named investor. Avelas Biosciences is developing a flourecent peptide which helps surgeons highlight cancer cells during surgery, specifically for breast cancer. READ MORE>>.

Avalon 138

Avalon San Diego Funding Capital 138

socalTECH

SEPTEMBER 10, 2014

San Diego-based Avelas Biosciences , which is developing cell penetrating peptides to light up cancerous tissue in patients during surgery, has raised $7.4M The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments. in a Series B funding. READ MORE>>.

Avalon 147

Avalon San Diego Venture Capital Research 147

socalTECH

NOVEMBER 28, 2016

San Diego-based biotechnology developer Synthorx announced today that it has named Patrick J. Synthorx is focused on developing novel protein therapeutics, and is venture backed by RA Capital Management, Avalon Ventures and Correlation Ventures. Doyle as its Chief Business Officer. READ MORE>>.

Avalon 100

Avalon San Diego Capital Funding 100

socalTECH

JULY 17, 2014

The latest venture capital totals from the PricewaterhouseCoopers/National Venture Capital Association''s MoneyTree Report was released this evening, tallying up $761.12M in investments in Q2 of 2014 in Southern California, up from Q2 of 2013, when $616.83M was invested in the region. Image courtesy Bigstock. READ MORE>>.

Southern California 240

Southern California El Segundo Culver City Orange County 240

socalTECH

APRIL 30, 2014

San Diego-based biopharmaceuticals developer Otonomy --which is developing treatments for inner and middle ear disorders--has roped in a big, $49M funding, the company announced this morning. The company said the new funding will go towards its product pipeline and a potential filing for regulatory approval of its lead compound.

Funding 138

Funding Avalon San Diego Capital 138

socalTECH

MARCH 13, 2014

San Diego-based AnaptysBio , a biopharmaceuticals firm focused on the development of therapeutic antibodies, announced a deal today with TESARO. According to AnaptysBio, it will receive an upfront license fee of $17M from TESARO, plus receive funding of costs incurred in related development programs, as part of an antibody program.

Avalon 138

Avalon San Diego Venture Capital Research 138

socalTECH

DECEMBER 6, 2012

The funding came from Avalon Ventures. Avelas is developing technology for visualizing cancerous lymph nodes in breast cancer patients. The firm's technology is based on technology developed by Nobel Prize winner Roger Tsien, Ph.D. The firm's CEO is currently Jay Lichter, who is also a Managing Director at Avalon Ventures.

Avalon 138

Avalon San Diego Study Technology 138

socalTECH

MARCH 21, 2014

San Diego-based Otonomy , a biopharmaceuticals company developing treatments for disorders of the inner and middle ear, said Thursday that it has added Vickie Capps to its board of directors. Capps also sits on the board of RF Surgical Systems and Consonance Capital Partners, and had been on the board of SenoRx. READ MORE>>.

Avalon 138

Avalon San Diego Capital Develop 138

socalTECH

MARCH 5, 2013

San Diego-based Carolus Therapeutics , a developer of biopharmaceuticals aimed at treating acute and chronic inflammation, has scored $2.25M in a debt funding round, according to financing provider Square 1 Bank. According to Square 1, the new funding will go support future growth at Carolus. READ MORE>>.

Avalon 147

Avalon Funding San Diego Develop 147

socalTECH

SEPTEMBER 4, 2013

According to the company, the funding was led by OrbiMed Advisors, and also included Aperture Venture Partners, Osage University Partners, as well as Avalon Ventures, Domain Associates, Novo Ventures, RiverVest Venture Partners and TPG Biotech. Khuong of OrbiMed wil join the company''s board with the funding. READ MORE>>.

Avalon 138

Avalon San Diego Equity Funding 138

socalTECH

AUGUST 18, 2016

San Diego-based biopharmaceuticals developer Avelas Biosciences has raised $20M in a Series C funding, according to the company. and laos included Ervington Investments Limited and Alexandria Venture Investments plus Avalon Ventures, Bregua Corporation, and WuXi Healthcare Ventures.

Avalon 100

Avalon San Diego Invest Funding 100

socalTECH

AUGUST 30, 2010

San Diego-based Otonomy , a biopharmaceuticals firm developing products to treat disorders of the inner and middle ear, announced today that it has raised $38.5M The round was led by Novo Ventures and RiverVest Venture Partners, and also includes Domain Associates, TPG Biotech, and Avalon Ventures. in a Series B financing.

Avalon 150

Avalon San Diego Venture Capital Study 150

socalTECH

APRIL 20, 2012

San Diego-based Chumby , which had developed Internet-connected, alarm-clock like devices and similar technology, has shut down, according to a report Friday.

Report 157

Report Avalon San Diego News 157

socalTECH

JUNE 9, 2009

San Diego-based aFraxis , a stealth-mode firm developing treatments for Fragile X Syndome and autism, has raised $750,000 in a funding round, according to a regulatory filing by the firm Tuesday. Details on the funding have not been announced, however, the company is venture backed by Avalon Ventures.

Avalon 100

Avalon San Diego Venture Capital Capital 100

socalTECH

JULY 21, 2011

San Diego-based Amira Pharmaceuticals , a developer of small molecule pharmaceuticals for treating inflammatory and fibrotic diseases, has agreed to be acquired by Bristol-Myers Squibb , the firms said late Thursday. Amira Pharmaceuticals was venture backed by Avalon Ventures, Novo A/S,Prospect Venture Partners, and Versant Ventures.

Avalon 150

Avalon San Diego Venture Capital Capital 150

socalTECH

JUNE 11, 2010

San Diego-based Otonomy , which is developing treatments for Meniere's disease, said today that it has raised $10M in a Series A financing round. The round came from Avalon Ventures. Otonomy is headed by Jay Lichter, who is also a managing director at Avalon Ventures. READ MORE>>.

Avalon 113

Avalon San Diego Study Capital 113

socalTECH

JUNE 9, 2010

San Diego-based Otonomy , a biopharmaceuticals firm developing drug therapies to treat inner and middle ear disorders, has raised $10.56M as part of an ongoing, $26.0M Source of the new funding was not disclosed, however, one of its founders, Jay Lichter, is at San Diego venture firm Avalon Ventures, which has previously backed the company.

Avalon 159

Avalon San Diego Venture Capital Capital 159

socalTECH

JUNE 4, 2012

San Diego-based Awarepoint , which develops real-time, location systems used for tracking patents and assets in a healthcare environment, said today that it has raised $14M in an additional financing round. HHIF contributed $7.5M

Avalon 140

Avalon San Diego Patents Invest 140

socalTECH

JUNE 1, 2010

Chumby develops a Wi-Fi enabled, Internet device which acts both as a clock as well as a connection into internet services like Weather, news, and more. Tags: chumby venture capital linux internet electronic device consumer. According to the filing, the firm is in the midst of raising up to $9.786M in the round. READ MORE>>.

Avalon 150

Avalon San Diego Venture Capital News 150

socalTECH

OCTOBER 4, 2010

Chumby has previously raised funding from Avalon Ventures, JK&B Capital, Masthead Venture Partners, and O'Reilly AlphaTech Ventures. Chumby's Internet device allows users to run information widgets, and includes tools for developers which makes it easy to create those software widgets to connect to Internet services.

Avalon 145

Avalon San Diego Venture Capital Software 145

socalTECH

DECEMBER 4, 2015

The funding was led by Avalon Ventures and TPG Biotech, and also included Correlation Ventures and Osage University Partners. The startup said it is developing novel drugs based on the anti-cancer activity of metformin and designed to reduce cancer energy production to treat a range of cancer types.

UCLA 100

UCLA Avalon San Diego Los Angeles 100

socalTECH

OCTOBER 24, 2011

San Diego-based Awarepoint , which develops systems for tracking equipment and patients in hospitals, reported today that it has hired four new executives onto its management team. Wallace was most recently at McKesson Corporation, as was Cosgrove; Arthur joins from Microsoft, and Gallecos from Cisco. READ MORE>>.

Avalon 124

Avalon San Diego Report Sales 124